Millions of women with overactive bladder have been invited to participate in a consultation that could provide over-the-counter treatment for the first time.
The call for evidence, launched on Saturday, could lead to the reclassification of Aquiette so that it can be bought from a pharmacy without a prescription.
One in six women in the UK is thought to have symptoms of an overactive bladder, such as a sudden, uncontrolled need to urinate, which can lead to accidental leaks.
Aquiette tablets are used to treat women with milder symptoms of the condition that cannot be controlled by bladder training alone.
The Agency for the Regulation of Medicines and Health Products (MHRA) calls on people with the disease, as well as health professionals with experience in its treatment, to share their views in the reclassification consultation.
Dr Laura Squire, chief health and access officer at MHRA, said: “For many women, an overactive bladder can make everyday life extremely challenging. It can affect relationships, work, social life and can lead to anxiety and depression.
“Fortunately, there are treatments and from today you will have the opportunity to express your opinion on whether one of these treatments, Aquiette, can be offered for the first time without a prescription.
Women’s Health Minister Maria Caulfield said: “When it comes to sensitive issues such as bladder control, talking to a GP can be a barrier for some women to seek help.
“Aquiette’s reclassification will allow women to access vital medicines without the need for a prescription.
The Committee for Medicinal Products for Human Use has advised that it is safe to buy Aquiette over the counter in pharmacies in the United Kingdom.
The consultation will last three weeks and end on May 6.
Add Comment